Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,339,054
-$141,569 QoQ
Shares Held
469,212
-9.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAXTON ASSOCIATES LLP holds $18,532,343 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
469,212 | $6,339,054 | |
| 2 | ZTS |
Zoetis Inc.
|
48,904 | $5,780,941 | |
| 3 | LQDA |
Liquidia Corp
|
117,075 | $4,418,410 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
80,456 | $1,000,068 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
35,313 | $798,073 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,567 | $195,797 |
All Filings in VTRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,339,054 | 469,212 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,480,623 | 520,532 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,084,531 | 513,589 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,367,852 | 265,157 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $119,309 | 13,698 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||